Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Abbott to market North American Vaccine's DTaP and related vaccines

Oct. 25, 1996

Spotlight on antiinfective vaccine research in the U.S.

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

Potential Chlamydia vaccine effective in preclinical studies

Oct. 18, 1996

University of Texas discloses OMPs for immunotherapy

Oct. 18, 1996

Lyme disease vaccine claimed by University of Minnesota

Oct. 18, 1996

Magainin discloses LAP for microbial infections

Oct. 18, 1996

New combination meningitis/hepatitis vaccine approved

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Successful reversal of acute kidney graft rejection with Thymoglobulin

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...